Evidence map›Paper›PMID 25670081›Full record

ArticleCancer cell2015

Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.

Lingtao Jin, Dan Li, Gina N Alesi, Jun Fan, Hee-Bum Kang, Zhou Lu, Titus J Boggon, Peng Jin, Hong Yi, Elizabeth R Wright and 11 more

Abstract read
In one paragraph

Article in Cancer cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 239 papers.

0numbers the graph read from it
0cells of the map it votes in
239citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

239 citing papers in PubMed, 356 citations in OpenAlex.

  1. Glutamine metabolism in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

179 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Lingtao JinWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Dan LiWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Gina N AlesiWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jun FanWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hee-Bum KangWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Zhou LuDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA.
Titus J BoggonDepartment of Pharmacology, Yale University, New Haven, CT 06520, USA.
Peng JinDepartment of Human Genetics, Emory University, Atlanta, GA 30322, USA.
Hong YiRobert P. Apkarian Integrated Electron Microscopy Core, Emory University, Atlanta, GA 30322, USA.
Elizabeth R WrightDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Duc DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Robert EgnatchikUT Southwestern Medical Center, Dallas, TX 75390, USA.
Ralph J DeBerardinisUT Southwestern Medical Center, Dallas, TX 75390, USA.
Kelly R MaglioccaDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA.
Martha L ArellanoWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hanna J KhouryWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Dong M ShinWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Fadlo R KhuriWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sumin KangWinship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: smkang@emory.edu.
Emory University · USSouthwestern Medical Center · USUniversity of Chicago · USYale University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Tyrosine Kinase Signaling in Cancer Cell MetabolismR01CA140515 · NCI · UNIVERSITY OF CHICAGO · PI Jing Chen · 2010 to 2026
$5.4M
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human CancersR01CA174786 · NCI · UNIVERSITY OF CHICAGO · PI CHEN, JING · 2014 to 2024
$3.7M
Transcription-dependent and -independent signaling of RSK2 in cancer metastasisR01CA175316 · NCI · EMORY UNIVERSITY · PI KANG, SUMIN · 2014 to 2023
$3.5M
METABOLIC REGULATORS OF TUMOR CELL GROWTHR01CA157996 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI DEBERARDINIS, RALPH J · 2011 to 2017
$2.2M
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effectR01CA183594 · NCI · EMORY UNIVERSITY · PI CHEN, JING · 2014 to 2018
$1.6M
FEI Transmission Electron Microscope with Tomography CapabilityS10RR025679 · NCRR · EMORY UNIVERSITY · PI SPEARMAN, PAUL W. · 2009 to 2009
$500k
p90RSK2-Stathmin Signaling in Metastatic Human CancersF31CA183365 · NCI · EMORY UNIVERSITY · PI ALESI, GINA NICOLE · 2014 to 2016
$112k
NCI NIH HHS F31 CA183365NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA140515NCI NIH HHS R01 CA157996NCI NIH HHS R01 CA174786NCI NIH HHS R01 CA175316NCI NIH HHS R01 CA183594NCRR NIH HHS S10 RR025679NCRR NIH HHS S10 RR025679-01
6 · The paper itself

Abstract

How mitochondrial glutaminolysis contributes to redox homeostasis in cancer cells remains unclear. Here we report that the mitochondrial enzyme glutamate dehydrogenase 1 (GDH1) is commonly upregulated in human cancers. GDH1 is important for redox homeostasis in cancer cells by controlling the intracellular levels of its product alpha-ketoglutarate and subsequent metabolite fumarate. Mechanistically, fumarate binds to and activates a reactive oxygen species scavenging enzyme glutathione peroxidase 1. Targeting GDH1 by shRNA or a small molecule inhibitor R162 resulted in imbalanced redox homeostasis, leading to attenuated cancer cell proliferation and tumor growth.

Indexed as

AntioxidantsCarcinogenesisFumaratesGene Expression Regulation, NeoplasticGlutamate DehydrogenaseGlutathioneGlutathione PeroxidaseGlutathione Peroxidase GPX1HumansKetoglutaric AcidsLeukemiaMitochondriaOxidation-ReductionPrimary Cell CultureReactive Oxygen SpeciesSignal TransductionAntioxidantsFumaratesGLUD1 protein, humanGlutamate DehydrogenaseGlutathioneGlutathione PeroxidaseGlutathione Peroxidase GPX1GPX1 protein, humanKetoglutaric AcidsReactive Oxygen Species

Identifiers

PMID25670081
PMCPMC4325424
OpenAlexW2003472128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.